# FDA Response Documentation-Gap Oracle Review Notes

Review ID: `fda_response_documentation_gap_oracle_review_20260603`
Predicate: `fda_response_documentation_gap(GapId, ViolationId, CgmpCitation, GapKind, Source)`
Fixture: `fda_warning_letter_domain_transfer_002`
Source: Rechon Life Science AB — 701040 — 04/30/2025 (CDER), Warning Letter 320-25-68.

## Blindness Statement

- Reviewer was blind to model outputs: **yes**
- Reviewer read forbidden inputs: **no**
- Notes: The forbidden inputs (`C:\prethinker\tmp\fda_t002_proposal_evidence.md`,
  `.json`, and `domain_lens_bundle\`) were not present in this packet and were not
  accessed. No model output, proposal-evidence summary, worksheet, or run log
  listing emitted candidate facts was read. The optional folder
  `allowed_inputs/existing_oracle_for_ids_only/` was used **only** to identify
  already-declared numbered violation IDs (`violation_1`..`violation_4`), their CGMP
  citation atoms, and existing source-faithfulness boundaries — never as model
  evidence for whether a documentation gap exists. That use is explicitly permitted
  by the work order.

## Overall Finding

No expected `fda_response_documentation_gap/5` facts are supported on this fixture.
The carrier fires only when the source states, in substance, that a firm **response
or corrective-action position** lacked supporting documentation, protocols, records,
or validation evidence for a specific numbered CGMP item. This letter never says the
firm failed to *provide* such material. Every response critique is the bare phrase
"Your response is inadequate" (items 1–3) or is absent (item 4). The expected set is
therefore empty, and the review instead records the boundaries the carrier must not
cross.

## Per-Item Adjudication

### Item 1 — `violation_1`, `cfr_21_211_113_b` (aseptic procedures / contamination control)
- Source language (paraphrase): Investigators observed a gloved-hand contact practice
  permitted by SOP-0870-3.0; FDA states the response is inadequate because the firm's
  *revised* procedure still allows the adjustment with sanitized gloved fingertips.
- Adjudication: **Do not emit.** The firm did submit a revised procedure; FDA reviewed
  it and found it substantively inadequate. That is a "response was inadequate" case
  (an explicit do-not-emit trigger), not a statement that documentation was not provided.

### Item 2 — `violation_2`, `cfr_21_211_192` (failure to investigate)
- Source language (paraphrase): EM-excursion and OOS investigations were inadequate;
  CAPAs to persistent contamination were not robust; OOS investigations lacked
  scientific rationale for root-cause determinations. Response is inadequate.
- Adjudication: **Do not emit.** This is fundamentally a failure-to-investigate critique
  tied to 211.192 and belongs to `fda_response_investigation_gap/5`, not the
  documentation-gap carrier. Explicit do-not-emit trigger ("really an investigation gap").

### Item 3 — `violation_3`, `cfr_21_211_42_c_10_v` (cleaning/disinfecting; aseptic)
- Source language (paraphrase): Firm failed to validate and assess effectiveness,
  distribution, and reproducibility of decontamination; investigators saw sticky ISO 8
  walls/floors with visible residue. Response is inadequate.
- Adjudication: **Abstain (do not emit).** The "failed to validate" wording is the
  underlying operational violation finding, not a statement that the firm's *response*
  lacked validation evidence. The response critique itself is only "Your response is
  inadequate." The source is ambiguous as to a response-documentation gap, so the
  carrier abstains rather than encode a prose guess.

### Item 4 — `violation_4`, `cfr_21_211_58` (good state of repair)
- Source language (paraphrase): Investigators observed peeling/bubbled paint and rust at
  an ISO 7 room providing access to an aseptic filling line.
- Adjudication: **Do not emit.** There is no response critique for item 4 at all, and
  `cfr_21_211_58` is outside this predicate's allowed citation value domain.

## Expected Facts

None. (See `candidate_expected_facts.pl` for the justified empty set.)

## Forbidden Facts

For each, the boundary and why it must not be emitted.

1. `fda_response_documentation_gap(_, violation_1, cfr_21_211_113_b, _, _).`
   - Boundary: response-inadequate-only mislabeled as a documentation gap.
   - Why: item 1's critique addresses a *provided* revised procedure that remains
     inadequate; the source never says documentation was not provided.

2. `fda_response_documentation_gap(_, violation_2, cfr_21_211_192, _, _).`
   - Boundary: investigation-gap critique mislabeled as a documentation gap.
   - Why: item 2 is a failure-to-investigate critique (211.192); it belongs to
     `fda_response_investigation_gap/5`.

3. `fda_response_documentation_gap(_, violation_3, cfr_21_211_42_c_10_v, _, _).`
   - Boundary: underlying-violation language promoted into a response documentation gap.
   - Why: item 3's response critique is only "inadequate"; the validation-failure wording
     describes the operational violation, not a stated response-documentation gap.

4. `fda_response_documentation_gap(_, violation_4, _, _, _).`
   - Boundary: documentation gap fabricated for an item with no response critique.
   - Why: item 4 has no response critique at all.

5. `fda_response_documentation_gap(_, violation_1, cfr_21_211_192, _, _).`
   - Boundary: documentation gap attached to the wrong citation.
   - Why: item 1's typed citation is `cfr_21_211_113_b`, not `cfr_21_211_192`.

6. `fda_response_documentation_gap(_, _, cfr_21_211_58, _, _).`
   - Boundary: citation outside the allowed value domain.
   - Why: `cfr_21_211_58` is not in this predicate's allowed `CgmpCitation` set.

7. `fda_response_documentation_gap(_, fei_3002806978, _, _, _).`
   - Boundary: facility identifier used as a violation ID.
   - Why: `ViolationId` must be a local numbered CGMP item atom (`violation_N`).

8. `fda_response_documentation_gap(_, rechon_life_science_ab, _, _, _).`
   - Boundary: recipient/firm name used as a violation ID.

9. `fda_response_documentation_gap(_, wl_320_25_68, _, _, _).`
   - Boundary: warning-letter / reference identifier used as a violation ID.

10. `fda_response_documentation_gap(_, _, _, sop_0870_3_0, _).`
    - Boundary: document/SOP title placed in the closed `gap_kind` slot.
    - Why: `gap_kind` is closed to {supporting_documentation, protocol_or_record,
      validation_evidence}.

11. `fda_response_documentation_gap(_, _, _, investigation_failure, _).`
    - Boundary: investigation-gap kind placed in the `gap_kind` slot.
    - Why: not an allowed `gap_kind`; conflates investigation gap with documentation gap.

12. `fda_response_documentation_gap(_, _, _, _, moraxella_osloensis).`
    - Boundary: organism name smuggled into the source/scope slot.

13. `fda_response_documentation_gap(_, _, _, _, 'Your response is inadequate.').`
    - Boundary: whole source phrase smuggled into the source/scope slot.

## Required Review Questions

1. **Which numbered CGMP item is being critiqued?**
   Items 1, 2, and 3 each carry a response critique ("Your response is inadequate");
   item 4 carries no response critique. None of these critiques is a documentation-gap
   critique for this carrier.

2. **Does FDA say material was not provided, or only that the response was inadequate?**
   Only that the response was inadequate (items 1–3). The letter never states that the
   firm failed to provide documentation, protocols, records, or validation evidence in
   its response.

3. **Is the missing material best represented as `supporting_documentation`,
   `protocol_or_record`, or `validation_evidence`?**
   Not applicable — no missing-response-material is stated. (If one were tempted to map
   item 3 to `validation_evidence`, that would conflate the underlying operational
   validation failure with a response-documentation gap; the carrier abstains instead.)

4. **Is the citation stated directly in the relevant item, or only inherited through the
   typed numbered-item context?**
   Each numbered item states its CGMP citation directly in its bolded heading
   (211.113(b); 211.192; 211.42(c)(10)(v); 211.58). The citations used for boundaries are
   taken from those headings via the existing numbered-item map.

## Integration Note

Per the work order, this review is candidate evidence only. The fixture oracle must not
be updated directly from it; promotion requires separate re-run through the proposal
evidence lane against the listed gates.
